Phesgo 1,200-600MG-30,000 unit 15ML
Ended Awarded
- Contract number
- SPE2DB25FNVWD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,225
Award facts
- Contract value 100% obligated
- $8,225.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of PHESGO (pertuzumab, trastuzumab, and hyaluronidase) in 1,200-600 mg formulations totaling 30,000 units of 15 ml each. This is a firm fixed-price delivery order with a ceiling value of $8,225.29 and a completion date of September 15, 2025. The order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime contract vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support program for military healthcare needs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company has demonstrated capability to compete successfully for federal pharmaceutical contracts across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This delivery order reflects the company's role within the DLA's pharmaceutical supply chain, supporting Defense Health Agency operations and other federal healthcare systems. All reviewed awards involving AmerisourceBergen have been competitively awarded with firm fixed-price structures, demonstrating the vendor's consistent ability to meet federal procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FNVWD?
SPE2DB25FNVWD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FNVWD worth?
The government has obligated $8,225 on SPE2DB25FNVWD.
Is contract SPE2DB25FNVWD an order under another contract?
Yes. SPE2DB25FNVWD is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNVWD competed?
The extent of competition for SPE2DB25FNVWD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award